Status:
COMPLETED
Metabolic Syndrome and Obstructive Sleep Apnea
Lead Sponsor:
Cairo University
Conditions:
Sleep Apnea
Metabolic Syndrome
Eligibility:
All Genders
22-77 years
Brief Summary
Background:Metabolic syndrome is a disorder characterized by abdominal obesity,hypertension,increased triglycerides ,decreased HDL cholesterol and increased blood glucose. Accumulating evidence strong...
Eligibility Criteria
Inclusion
- Patients fulfilled the criteria of OSA ( obstructive sleep apnea) in the form of symptoms suggestive of OSA (daytime sleepiness/daytime fatigue/headache/snoring)and with AHI ( apnea-hyponea index) ≥5.
Exclusion
- Cerebro-vascular accident within the preceding 30 days.
- Patients on sedatives.
- Patients on anti-psychotics
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06051097
Start Date
September 1 2022
End Date
May 15 2023
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr alainy school of medicine
Cairo, Egypt, 11562